1 treatment center
No centers match
Try a different search term
1 SAMHSA-listed treatment center in Bloomfield, Indiana. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Try a different search term
Free, confidential assistance matching you with the right program in Bloomfield.
Bloomfield, Indiana has 1 SAMHSA-verified addiction treatment center offering 1 residential rehab, 1 dual diagnosis, 1 detox. Each facility listed here is verified through the Substance Abuse and Mental Health Services Administration (SAMHSA) and provides evidence-based treatment approaches.
Residential treatment programs in Bloomfield provide 24/7 structured care in a substance-free environment. These programs typically last 30 to 90 days and include individual therapy, group counseling, and life skills training.
Treatment centers in Bloomfield accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Admission to a Bloomfield treatment program typically follows a five-step path: (1) initial phone screening with admissions, (2) insurance verification (24-48 hours), (3) full clinical assessment using ASAM criteria (in-person or telehealth), (4) admission date scheduling and pre-admission logistics, (5) arrival, intake paperwork, medical evaluation, and program entry. Same-week admission is common when bed availability aligns; same-day is possible for urgent presentations at facilities maintaining rolling capacity.
The first 90 days post-discharge are the highest-relapse-risk window for Bloomfield patients leaving residential treatment — multiple studies place 60-70% of relapses within this window. Structured continuity matters: same-team outpatient continuity, scheduled check-ins, structured-day expectations, and mutual-support engagement reduce 90-day relapse risk substantially compared to discharge-and-good-luck approaches. Programs that build this continuity into their model report measurably better outcomes than those treating discharge as the program endpoint.
Pregnant women in Bloomfield with active substance use should not stop opioid use abruptly if dependent — withdrawal during pregnancy carries fetal risk including preterm labor and stillbirth. Evidence-based care is buprenorphine or methadone maintenance (NOT detox), continued through pregnancy and postpartum. Indiana maternal-fetal medicine specialists, OB-GYNs trained in addiction medicine, and SAMHSA's Center of Excellence for Pregnant and Postpartum Women with Opioid Use Disorder provide specialized care pathways for this population.
Most Bloomfield patients enter treatment at one of three levels: medically managed detox (if withdrawal risk warrants medical supervision), residential treatment (24-hour structured environment for those without stable recovery support at home), or intensive outpatient (9+ hours/week of programming for those able to maintain work/school and recover at home with structured support). The choice depends on ASAM criteria assessment performed by licensed clinicians, not solely on patient preference or insurance coverage limitations.
Bloomfield sits within Indiana's broader addiction-treatment infrastructure — a network of licensed providers ranging from medically supervised detox facilities through residential treatment, partial hospitalization, intensive outpatient, and standard outpatient counseling. Patients seeking care in Bloomfield have access to options at multiple intensity levels, with placement decisions driven by ASAM criteria: withdrawal risk, biomedical conditions, emotional/behavioral status, readiness to change, relapse potential, and the patient's current recovery environment. The specific providers verified for Bloomfield below represent facilities that have been confirmed against SAMHSA's treatment-locator database and Indiana licensing records.
Personality disorders — particularly borderline personality disorder and antisocial personality disorder — are common in addiction-treatment populations and shape both treatment course and outcome. Bloomfield programs increasingly incorporate Dialectical Behavior Therapy (DBT) skills training, mentalization-based therapy, and structured approaches to interpersonal-effectiveness building. Treatment for personality-disorder patterns typically requires longer treatment episodes than substance-only presentations and ongoing therapy well beyond the formal program completion.
Federal parity protections extend beyond just coverage existence to specific plan design elements: prior authorization burden, treatment day limits, financial requirements, and non-quantitative treatment limits must all be comparable between substance-use and medical/surgical benefits. Bloomfield patients encountering insurer practices that appear to discriminate against addiction-treatment access can file complaints with the Indiana Department of Insurance, the U.S. Department of Labor (for ERISA plans), or the federal Center for Consumer Information and Insurance Oversight.